SRRK Q2 2021 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+17.8% YoY

Gross Profit

-$21M-457.2% margin

Operating Income

-$30M-658.8% margin

Net Income

-$31M-668.3% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$332M

Total Liabilities

$115M

Stockholders' Equity

$217M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+17.8%
Gross Profit	-$21M	-$12M	-73.7%
Operating Income	-$30M	-$19M	-55.5%
Net Income	-$31M	-$19M	-59.3%